PBM

Healthcare Biotechnology

Psyence Biomedical Ltd.

$5.08

-0.22 -4.15% today

Price History

Not enough data

Key Stats

Market Cap

19.38M

Avg Volume

91,721

EPS

-$12.56

52W High

$175.78

52W Low

$1.92

Div. Yield

0.0%

Valuation

P/B Ratio

0.69

EV/EBITDA

-1.96

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(58.6%)

Return on Assets

(31.3%)

Liquidity & Leverage

Current Ratio

14.62

Quick Ratio

12.12

Total Cash

7.44M

Total Debt

About

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.

psyencebiomed.com